Mental health frameworks have long treated fear, anxiety, and suicidal ideation as points on a single severity scale — a clinically convenient but neurologically inaccurate picture. A new circuit-based model published in Neuroscience and Biobehavioral Reviews challenges this continuum assumption, arguing instead that each state reflects a fundamentally different mode of neural organization, with distinct implications for how these conditions develop, persist, and potentially respond to intervention.
The proposed framework maps three progressively distinct neural configurations. Fear is characterized as phasic and stimulus-locked, driven by rapid amygdala microcircuit responses calibrated to immediate external threat. Anxiety represents a temporal expansion of this threat processing: the bed nucleus of the stria terminalis (BNST) assumes greater regulatory influence, insula-anterior cingulate cortex networks amplify interoceptive signals, and prefrontal inhibitory control weakens — producing sustained anticipatory arousal decoupled from any discrete trigger. Suicidal brain states constitute a third configuration altogether, marked by internalization of threat within self-referential neural systems. Disrupted coupling between default mode network hubs and salience circuits may drive persistent negative self-processing, while compromised frontostriatal pathways and reduced serotonergic tone may erode behavioral inhibition, increasing vulnerability to impulsive action.
This framework carries meaningful implications for neuroscience and clinical psychiatry. Current pharmacological approaches — SSRIs, benzodiazepines, anxiolytics — largely target shared monoamine or GABAergic pathways without distinguishing between these circuit modes. If suicidal states genuinely involve default mode network dysregulation and frontostriatal dysfunction rather than simply elevated amygdala activity, treatments specifically modulating DMN connectivity or serotonergic frontostriatal tone may hold greater promise. Notably, this remains a theoretical review rather than an empirical trial: the framework synthesizes existing neuroimaging and animal-model literature rather than presenting new primary data. Its strength lies in mechanistic coherence, but longitudinal human studies directly tracking circuit transitions are still needed. The model is best viewed as a conceptual advance that should redirect experimental design rather than immediately alter clinical practice.